Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial

DOI Full Paper Access

39

Citations

29

References

2018

Year

Aneliya Parvanova, Matias Trillini, Manuel Alfredo Podestà, Ilian Iliev, Carolina Aparicio, Annalisa Perna, Francesco Peraro, Nadia Rubis, Flavio Gaspari, Antonio Cannatà,

Journal of the Endocrine Society

Abstract

Six-month oral ALC supplementation did not affect blood pressure, lipid and glycemic control, insulin sensitivity and kidney function in hypertensive normoalbuminuric and microalbuminuric T2D patients on background statin therapy.

References

	Year	Citations

Page 1